Immunotherapy is now recognized as an essential component of treatment for a wide variety of cancers. It is an interdisciplinary field that is critically dependent upon an improved understanding of a vast network of cross-regulatory cellular populations and a diversity of molecular effectors; it is a leading example of translational medicine with a favorable concept-to-clinical-trial timeframe of just a few years. There are many established immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use. Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmap leading to the creation of these future cancer-fighting immunotherapies. It includes essays by leading researchers that cover a wide variety of topics including T cell and non-T cell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymal stromal cells, negative regulators in cancer immunology and immunotherapy, non-cellular aspects of cancer immunotherapy, the combining of cancer vaccines with conventional therapies, the combining of oncolytic viruses with cancer immunotherapy, transplantation, and more. The field of immunotherapy holds great promise that will soon come to fruition if creative investigators can bridge seemingly disparate disciplines, such as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapy,non-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combining of oncolytic viruses with cancer immunotherapy,transplantation, and more. The field of immunotherapy holds great promise that willsoon come to fruition if creative investigators can bridge seemingly disparate disciplines,such as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Questo è un articolo print on demand. Bestandsnummer des Verkäufers b0095303475157fb3deac36deeddfe41
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9781627038225_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Lucky's Textbooks, Dallas, TX, USA
Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar2811580170233
Anzahl: Mehr als 20 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reflects the inter-disciplinary nature of translational immunotherapy, and includes a description of the cellular players/molecular effectors and the distinct therapeutic strategies Ideal for laboratory researchers and post-baccalaureate level students Each. Bestandsnummer des Verkäufers 4267743
Anzahl: Mehr als 20 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapy,non-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combining of oncolytic viruses with cancer immunotherapy,transplantation, and more. The field of immunotherapy holds great promise that willsoon come to fruition if creative investigators can bridge seemingly disparate disciplines,such as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge. 460 pp. Englisch. Bestandsnummer des Verkäufers 9781627038225
Anzahl: 2 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Experimental and Applied Immunotherapy | Daniel Fowler (u. a.) | Taschenbuch | xvii | Englisch | 2014 | Humana | EAN 9781627038225 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Bestandsnummer des Verkäufers 105066644
Anzahl: 5 verfügbar
Anbieter: California Books, Miami, FL, USA
Zustand: New. Bestandsnummer des Verkäufers I-9781627038225
Anzahl: Mehr als 20 verfügbar
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. Experimental and Applied Immunotherapy offers a roadmap to the creation of immunotherapies, which have prominent cancer-fighting potential. Readers will find discussions of T cell and non-T cell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, and more. Editor(s): Medin, Jeffrey; Fowler, Daniel L.T. Num Pages: 459 pages, 24 black & white tables, biography. BIC Classification: MJCM; PSF. Category: (G) General (US: Trade). Dimension: 235 x 155 x 24. Weight in Grams: 700. . 2014. Paperback. . . . . Bestandsnummer des Verkäufers V9781627038225
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapynon-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combining of oncolytic viruses with cancer immunotherapytransplantation, and more. The field of immunotherapy holds great promise that willsoon come to fruition if creative investigators can bridge seemingly disparate disciplinessuch as T cell therapy, gene therapy, and transplantation therapy. This text is a vital tool in the building of that bridge.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 460 pp. Englisch. Bestandsnummer des Verkäufers 9781627038225
Anzahl: 1 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Bestandsnummer des Verkäufers 26357314701